2 months ago
CLDX
AnalystsYatin SunejaYatin Suneja's Stock Forecasts
AnalystsYatin Suneja
Analyst Ranking
Bottom 15%
#3920 out of 4554 analysts
Average Return
-1.27%
Win Rate
44%32 out of 73
Risk vs Reward
Poor
Good
Yatin Suneja's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Reata Pharmaceuticals IncRETA | +376.00% | $36.21 | $172.36 | 2022-10-18 - 2023-09-25 | Strong Buy |
Eyepoint Pharmaceuticals IncEYPT | +185.48% | $6.13 | $17.50 | 2023-05-17 - 2024-04-18 | Strong Buy |
Prometheus Biosciences IncRXDX | +102.65% | $18.85 | $38.20 | 2021-04-05 - 2022-04-05 | Strong Buy |
Acadia Pharmaceuticals IncACAD | +89.09% | $16.32 | $30.86 | 2023-01-02 - 2024-01-02 | Strong Buy |
Moonlake ImmunotherapeuticsMLTX | +86.12% | $22.70 | $42.25 | 2023-04-30 - 2024-04-18 | Strong Buy |
Yatin Suneja Analyst Color
Get additional color on Yatin Suneja's coverage of popular stocks
2 months ago
AXSM
4 months ago
LBPH
9 months ago
ARGX
9 months ago
ARGX
a year ago
LRMR
a year ago
RXDX
Yatin Suneja's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Celldex Therapeutics IncCLDX | 4 | Strong Buy | $90.00 | +133.58% | Maintains | 2 months ago |
Axsome Therapeutics IncAXSM | 7 | Strong Buy | $125.00 | +90.20% | Maintains | 2 months ago |
Longboard Pharmaceuticals IncLBPH | 3 | Strong Buy | $32.00 | +77.68% | Maintains | 4 months ago |
Roivant Sciences LtdROIV | 2 | Strong Buy | $16.00 | +54.44% | Maintains | 5 months ago |
Moonlake ImmunotherapeuticsMLTX | 3 | Strong Buy | $77.00 | +82.25% | Maintains | 5 months ago |
Tourmaline Bio IncTRML | 1 | Strong Buy | $50.00 | +219.28% | Initiates Coverage On | 6 months ago |
Neumora Therapeutics IncNMRA | 1 | Strong Buy | $22.00 | +108.53% | Initiates Coverage On | 6 months ago |
Immunovant IncIMVT | 3 | Strong Buy | $32.00 | +12.99% | Reiterates | 7 months ago |
Cabaletta Bio IncCABA | 2 | Strong Buy | $34.00 | +143.38% | Reiterates | 8 months ago |
Argenx SeARGX | 3 | Strong Buy | $590.00 | +64.62% | Maintains | 9 months ago |
Regeneron Pharmaceuticals IncREGN | 3 | Strong Buy | $900.00 | +0.67% | Maintains | 9 months ago |
Zura Bio LtdZURA | 1 | Strong Buy | $20.00 | +442.01% | Initiates Coverage On | 10 months ago |
Xenon Pharmaceuticals IncXENE | 2 | Strong Buy | $49.00 | +21.56% | Reiterates | 10 months ago |
Eyepoint Pharmaceuticals IncEYPT | 2 | Strong Buy | $55.00 | +214.29% | Maintains | a year ago |
Larimar Therapeutics IncLRMR | 3 | Strong Buy | $14.00 | +119.44% | Maintains | a year ago |
Anaptysbio IncANAB | 5 | Strong Buy | $45.00 | +126.93% | Maintains | a year ago |
Bioxcel Therapeutics IncBTAI | 2 | Strong Buy | $46.00 | +1,703.92% | Maintains | a year ago |
Neurocrine Biosciences IncNBIX | 1 | Strong Buy | $145.00 | +9.40% | Upgrades | a year ago |
Biogen IncBIIB | 3 | Strong Buy | $350.00 | +83.71% | Upgrades | a year ago |
Prometheus Biosciences IncRXDX | 3 | Hold | $200.00 | N/A | Downgrades | a year ago |
Inflarx NvIFRX | 2 | Strong Buy | $8.00 | N/A | Upgrades | a year ago |
Rapt Therapeutics IncRAPT | 2 | Strong Buy | $48.00 | N/A | Maintains | a year ago |
Acadia Pharmaceuticals IncACAD | 5 | Strong Buy | $22.00 | N/A | Upgrades | a year ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Hold | $116.50 | N/A | Downgrades | a year ago |
Surrozen IncSRZN | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Vigil Neuroscience IncVIGL | 1 | Strong Buy | $19.00 | N/A | Maintains | a year ago |
Sage Therapeutics IncSAGE | 3 | Strong Buy | $48.00 | N/A | Maintains | a year ago |
Phathom Pharmaceuticals IncPHAT | 2 | Strong Buy | $30.00 | N/A | Maintains | a year ago |
Reata Pharmaceuticals IncRETA | 1 | Strong Buy | $75.00 | N/A | Initiates Coverage On | 2 years ago |
Relmada Therapeutics IncRLMD | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Karuna Therapeutics IncKRTX | 1 | Strong Buy | $330.00 | N/A | Maintains | 2 years ago |
Bausch & Lomb CorpBLCO | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 2 years ago |
Eliem Therapeutics IncELYM | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Seelos Therapeutics IncSEEL | 1 | Strong Buy | $240.00 | N/A | Initiates Coverage On | 3 years ago |
Global Blood Therapeutics IncGBT | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Seagen IncSGEN | 1 | Strong Buy | $80.00 | N/A | Upgrades | 6 years ago |
Verona Pharma PLCVRNA | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.